FDA authorizes second COVID-19 pill, from Merck

...

This authorization is more limited than one on Wednesday for a Pfizer pill. The FDA authorized the Merck pill, developed with Ridgeback Biotherapeutics, for high-risk adults "for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate."

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Covid is here for good, scientists say. The rest remains unpredictable.

Covid could take on a similar ebb and flow to the flu, but there is plenty left to figure out about just how severe and disruptive it will continue to be.

SEATTLE — Early in the pandemic, many people seized on the hope that Covid-19 could be stopped in its tracks and buried for good once vaccines rolled out.

But hope for a zero-Covid country fizzled for most scientists long ago. 

“Everyone has stopped talking about getting rid of Covid,” Dr. Elizabeth Halloran, an epidemiologist at the Fred Hutchinson Cancer Research Center in Seattle, said of her fellow researchers. “It’s not going away, and that means it’s going to be endemic.” 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

'Enormous spread of omicron' may bring 140M new COVID infections to US in the next two months, model predicts

Omicron Infections Seem to Be Milder, Three Research Teams Report, but more contageous

Three separate teams of scientists on two continents have found that Omicron infections more often result in mild illness than earlier variants of the coronavirus, offering hope that the current surge may not be quite as catastrophic as feared despite skyrocketing caseloads.

The researchers examined Omicron’s course through populations in South Africa, Scotland and England. The results in each setting, while still preliminary, all suggested that the variant was less likely to send people in hospitals.

“Given that this is everywhere and given that it’s going to be so transmissible, anything that would lower severity is going to be better,” said Natalie Dean, a biostatistician at Emory University in Atlanta.

Problem, Solution, SitRep, or ?: 

Supreme Court announces it will hear challenges to vaccine mandates in early January

France cancels order for Merck's COVID-19 antiviral drug

Native Americans hit worse as the COVID pandemic fueled the drug crisis

mRNA booster shots provide 'significant increase' in protection against Omicron -- new Danish study

Two studies indicate reduced risk of Omicron hospitalization but WHO says too soon to evaluate severity

Early studies suggest a reduced risk of Covid-19 hospitalization when infected with Omicron compared to Delta --CNN overview

(CNN) Two new preprint papers add to the growing evidence that the Omicron coronavirus variant may be less likely to cause severe disease and hospitalization compared to the Delta variant.

Problem, Solution, SitRep, or ?: 

US FDA authorizes Pfizer pill to treat COVID-19 at home, in major advance

WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Missouri, Cleveland Covid situations

WHO predicts 'significant surge' in European cases

The World Health Organization's (WHO) regional director for Europe is warning that countries in the region should prepare for a "significant surge" in COVID-19 cases.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US population growth drops in pandemic’s 1st year to lowest rate since country's founding

OVERVIEW: U.S testing kits rationed in stores, South Africa registers fewer cases

Overview: Europe and Asia Covid developments

Pages

Subscribe to Global RSS
howdy folks
Page loaded in 1.200 seconds.